| All patients |
---|
Patient characteristics | AMI | No AMI | Total |
---|
Positive cTnI | 32 | 9 | 41 |
Negative cTnI | 13 | 263 | 276 |
Total | 45 | 272 | 317 |
Positive HsTnT | 42 | 48 | 90 |
Negative HsTnT | 3 | 224 | 227 |
Total | 45 | 272 | 317 |
|
Low to moderate PTP
|
|
AMI
|
No AMI
|
Total
|
Positive cTnI | 17 | 7 | 24 |
Negative cTnI | 5 | 229 | 234 |
Total | 22 | 236 | 258 |
Positive HsTnT | 20 | 36 | 56 |
Negative HsTnT | 2 | 200 | 202 |
Total | 22 | 236 | 258 |
- aNet reclassification improvement (NRI) from the use of highly sensitive troponin T (HsTnT) was 7.9% (95% CI = 0.9 to 14.9; P = 0.034). Comparison of the model including HsTnT with cTnI was significant for low PTP patients (NRI = 10.3%, 95% CI = 1.9 to 18.7; P = 0.027), but NRI was not significantly different in moderate PTP patients (NRI = 11.6%, 95% CI = -0.5 to 23.7; P = 0.084) or in high PTP patients (NRI = -14.4%, 95% CI = -32.6 to -3.6; P = 0.181).